Medical News

RSS

FDA grants IDE approval for Urovalve's Surinate Bladder Management System

Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.

29 Mar 2010

Closing Medicare drug gap helps Democrats sell reform

Kaiser Health News writer Christopher Weaver, in a story produced in collaboration with the Los Angeles Times, looks at the government's plan to close the Medicare prescription drug "doughnut hole."

29 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

HealthCare.com, Inc. the leader in online health insurance information and plan quotes, today announced the launch of MedicareSupplemental.com, a new website aimed to be the premier online resource for Medicare Supplemental information and quotes. The website provides extensive information to help consumers understand the complexities of Medicare Supplemental or "Medigap" coverage as well as a search tool to obtain quotes and connect with multiple brokers and agents.

29 Mar 2010

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Novavax, Inc. a clinical-stage vaccine company, released the final results from a Phase II clinical trial evaluating Novavax's trivalent seasonal influenza Virus-like particle (VLP) vaccine candidate in healthy adults. The study enrolled healthy volunteers 18 to 49 years in age who were immunized with a single injection of Novavax's trivalent seasonal influenza VLP vaccine matched to the influenza strains recommended for the 2008-2009 influenza vaccine.

29 Mar 2010

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.

29 Mar 2010

AlphaRx plans listing of subsidiary on Canadian exchange

AlphaRx, Inc. today announced that the Company plans to list its' Canadian subsidiary, which has been focused on China and emerging markets, on a Canadian exchange in a transaction that will result in two independent and highly focused public companies - one dedicated to the Far East and one to developed markets.

29 Mar 2010

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Oxygen Biotherapeutics, Inc. today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen Concentrate for the beauty and skin care market. The over-the-counter product is a scientifically designed perfluorocarbon concentrate to enhance oxygen delivery to skin.

29 Mar 2010

China Medicine's 2009 revenues up 20.7%

China Medicine Corporation, primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines, and other nutraceuticals, today announced its fourth quarter and full year 2009 results.

29 Mar 2010

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

29 Mar 2010

'Ultra-high' Medicare billing program causes waste, abuse

The Washington Post: Federal investigators are examining a Medicare billing program to see if it is being abused by nursing home operators. "More than a decade ago, Congress ... created new 'ultra-high' billing categories intended to be used for only 5 percent of the patients needing highly specialized care and rehabilitation.

29 Mar 2010

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

Celerion, a privately owned contract research organization (CRO), has completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services. The acquired assets include five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and Belfast, Northern Ireland, as well as operations in Richmond, Virginia and Quebec, Canada.

29 Mar 2010

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today it has entered into exclusive license, supply and distribution agreements with Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd., an India-based pharmaceutical company. Pursuant to the agreements, Parenteral is authorized to register, supply and distribute Sinovac's Anflu (seasonal influenza vaccine) and PANFLU.1 (H1N1 vaccine) to the government of India and private market in India. Currently, the registration process is ongoing in India.

29 Mar 2010

Enrollment complete in Gemin X Pharmaceuticals' Phase 2 clinical trial of obatoclax for SCLC

Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.

29 Mar 2010

Health reform will create demand for primary care physicians, rural docs especially squeezed

The Associated Press: "Primary care physicians already are in short supply in parts of the country, and the landmark health overhaul that will bring them millions more newly insured patients in the next few years promises extra strain. ... Recently published reports predict a shortfall of roughly 40,000 primary care doctors over the next decade, a field losing out to the better pay, better hours and higher profile of many other specialties.

29 Mar 2010

Upgrading to policy with no limits benefits insurance agent

It can be instructive to consider not just what long term care insurance professionals recommend, but what they do -- for their own personal protection. A good example is the case of Kim Galatolo, an agent with LTC Financial Partners LLC one of the nation's most experienced long term care insurance agencies. In California, where Galatolo lives and works, the firm is known as LTC Partners & Insurance Services, LLC.

29 Mar 2010

New ezine to help ensure regulatory and ethical compliance in research involving lab animals

A new, free weekly ezine, Lab Animal e-Alert, helps scientists whose research involves lab animals assure regulatory and ethical compliance in their use. Its format is a reader question followed by an answer from an expert.

29 Mar 2010

Genta reports net loss of $11.7M for fourth-quarter 2009

Genta Incorporated today reported results for the quarter and year ended December 31, 2009. The Company also provided an overview of recent corporate highlights and anticipated milestones.

29 Mar 2010

Dr. Siegal's COOKIE DIET products available in New York City from Dr. Shapiro

Dr. Siegal's Direct Nutritionals, LLC, the global distributor of Dr. Siegal's COOKIE DIET® brand products, today announced that it has begun supplying its products to the New York City medical practice of obesity expert and bestselling author Dr. Howard Shapiro. Dr. Shapiro is the only physician in New York City to whom Dr. Siegal's COOKIE DIET® products are supplied.

29 Mar 2010

PG Tips Black Tea promotes sound mind and nourished body

With the warmer weather and longer days starting to settle in, that can only mean one thing: time to break out of the winter hibernation mode, bust out the summer wardrobe and get out there! And no matter what the occasion or setting, Black is Back™ with PG Tips Black Tea, a refreshing, revitalizing and forward-thinking interpretation of a cultural classic.

29 Mar 2010

Medical News

FDA grants IDE approval for Urovalve's Surinate Bladder Management System

Closing Medicare drug gap helps Democrats sell reform

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

AlphaRx plans listing of subsidiary on Canadian exchange

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

China Medicine's 2009 revenues up 20.7%

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

'Ultra-high' Medicare billing program causes waste, abuse

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Enrollment complete in Gemin X Pharmaceuticals' Phase 2 clinical trial of obatoclax for SCLC

Health reform will create demand for primary care physicians, rural docs especially squeezed

Upgrading to policy with no limits benefits insurance agent

New ezine to help ensure regulatory and ethical compliance in research involving lab animals

Genta reports net loss of $11.7M for fourth-quarter 2009

Dr. Siegal's COOKIE DIET products available in New York City from Dr. Shapiro

PG Tips Black Tea promotes sound mind and nourished body

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News